Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combined Effect of Diabetes and cyp2c19 Polymorphism on Clopidogrel VS Ticagrelor Antiplatelet Activity in Patients of Anterior ST Elevation Myocardial Infarction Undergoing Primary PCI

NCT03613857 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.

NCT NCT03613857
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03613857 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combined Effect of Diabetes and cyp2c19 Polymorphism on Clopidogrel VS Ticagrelor Antiplatelet Activity in Patients of Anterior ST Elevation Myocardial Infarction Undergoing Primary PCI
Lead sponsor
Cairo University
Phase
Observational
Overall status
Completed
Start date
April 15, 2017
Completion date
July 28, 2018
Enrollment
1,022 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myocardial infarction